Taysha Gene Therapies has announced an important milestone for the Queen’s University clinical trial for TSHA-118, a CLN1 disease clinical trial funded by Taysha Gene Therapies. Please read the community letter here

Taysha Gene Therapies has announced an important milestone for the Queen’s University clinical trial for TSHA-118, a CLN1 disease clinical trial funded by Taysha Gene Therapies. Please read the community letter here

Please read the community letter here:

A Letter to the CLN1 Community from Taysha

By Morgan Deboth|2021-12-16T18:10:49-05:00December 16th, 2021|Latest News|Comments Off